MARKET

IPDQF

IPDQF

Impedimed
OTCPK
0.012
NaN%
Opening 09:30 12/05 EST
OPEN
--
PREV CLOSE
0.012
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.046
52 WEEK LOW
0.0099
MARKET CAP
24.04M
P/E (TTM)
-1.5526
1D
5D
1M
3M
1Y
5Y
1D
ImpediMed Expands U.S. Insurance Coverage for Lymphoedema Assessment
TipRanks · 1d ago
ImpediMed Strengthens Financial Position with R&D Tax Incentive Refund
TipRanks · 11/24 06:37
ImpediMed Limited Successfully Concludes Annual General Meeting with All Resolutions Passed
TipRanks · 11/18 03:37
ImpediMed’s 2025 AGM: Advancing Healthcare Standards
TipRanks · 11/18 01:28
Impedimed Limited Reports Strong Growth and Strategic Focus at 2025 AGM
TipRanks · 11/18 01:28
ImpediMed Director Increases Shareholding in Strategic Move
TipRanks · 11/06 11:59
ImpediMed Director Increases Stake Through Share Acquisition
TipRanks · 11/06 11:59
ImpediMed Director Increases Shareholding Through Fee Conversion
TipRanks · 11/06 11:58
More
About IPDQF
ImpediMed Limited is an Australia-based medical technology company. The Company uses bioimpedance spectroscopy (BIS) technology to generate data to maximize patient health. The Company designs and manufactures medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the noninvasive clinical assessment and monitoring of fluid status and tissue composition. The Company’s SOZO Digital Health Platform is a Food and Drug Administration (FDA)-cleared bioimpedance spectroscopy (BIS) solution for the clinical assessment of lymphedema. Its SOZO Applications include L-Dex Analysis for Lymphedema, BodyComp Analysis, Segmental BodyComp Analysis, and HF-Dex Analysis for Heart Failure. Its product SFB7 measures fluid status and tissue composition for clinical and research applications. Its ImpediVET is a single-channel, tetrapolar bioimpedance spectroscopy (BIS) device that measures fluid status and tissue composition for veterinary applications.

Webull offers ImpediMed Ltd stock information, including OTCPK: IPDQF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IPDQF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IPDQF stock methods without spending real money on the virtual paper trading platform.